Health ❯Healthcare ❯Cancer Immunotherapy ❯Checkpoint Inhibitors
It demonstrates that intravesical BCG triggers immune training in the bone marrow, with preclinical models showing enhanced tumor control when combined with checkpoint inhibitors.
